Does Coronary Angiography Cause Cognitive Dysfunction?

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Per Tornvall, Karolinska Institutet

ClinicalTrials.gov Identifier:

NCT01428947

First received: August 26, 2011

Last updated: February 23, 2016

Last verified: February 2016

History of Changes

Purpose

The purpose of the study is to study if coronary angiography cause cognitive dysfunction.

Condition	Intervention
Coronary Heart Disease Heart Valve Diseases	Procedure: Arterial approach


Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Prospective
Official Title:	Study of Cognitive Function Before and After Coronary Angiography

Resource links provided by NLM:

MedlinePlus related topics: Heart Valve Diseases

U.S. FDA Resources

Further study details as provided by Karolinska Institutet:

Primary Outcome Measures:

Change in cognitive dysfunction from baseline to two days after coronary angiography [ Time Frame: Baseline and two days ] [ Designated as safety issue: Yes ]
The Montreal Cognitive Assesment test will be performed before, 2 and 30 days after coronary angiography

Secondary Outcome Measures:

Number of patients with cerebral microemboli [ Time Frame: Baseline ] [ Designated as safety issue: Yes ]
Cerebral microembolism will be studied by transcraniell doppler at the time of angiography. Findings will be related to change in cognitive function between baseline and two days.


Enrollment:	80
Study Start Date:	September 2011
Study Completion Date:	June 2012
Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
Coronary angiography Patents scheduled for elective coronary angiography	Procedure: Arterial approach Randomization to right radial or femoral approach Other Name: Coronary arteriography

Detailed Description:

We have previously shown, using transcranial doppler, that coronary angiography cause cerebral microembolism. Cerebral microemboli were more common using the radial than femoral approach. Previously, cerebral microembolism has been associated with new cerebral lesions on MRI. The clinical significance of these new lesions is not determined. The primary aim of this pilot study is to see if coronary angiography cause cognitive dysfunction determined by the MoCA-test. A secondary aim is to relate cognitive dysfunction to cerebral microembolism measured by transcranial doppler. A third aim is to study potential differences between the femoral and radial approaches.

Eligibility


Ages Eligible for Study:	35 Years to 90 Years (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Patients scheduled for elective coronary angiography at one center

Criteria

Inclusion Criteria:

Elective coronary angiography irrespective of cause

Exclusion Criteria:

Previous CABG, language problems, not willing to participate

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01428947

Locations


Sweden
Cardiology Clinic, Karolinska University Hospital
Stockholm, Sweden, 17176

Sponsors and Collaborators

Karolinska Institutet

Investigators


Principal Investigator:	Per - Tornvall, MD, PhD	Karolinska Institutet

More Information

Publications:

Jurga J, Nyman J, Tornvall P, Mannila MN, Svenarud P, van der Linden J, Sarkar N. Cerebral microembolism during coronary angiography: a randomized comparison between femoral and radial arterial access. Stroke. 2011 May;42(5):1475-7. doi: 10.1161/STROKEAHA.110.608638. Epub 2011 Mar 10.


Responsible Party:	Per Tornvall, Docent, Karolinska Institutet
ClinicalTrials.gov Identifier:	NCT01428947 History of Changes
Other Study ID Numbers:	KI-angio-2
Study First Received:	August 26, 2011
Last Updated:	February 23, 2016
Health Authority:	Sweden: Institutional Review Board

Additional relevant MeSH terms:


Heart Diseases Coronary Disease Coronary Artery Disease Myocardial Ischemia Heart Valve Diseases	Cardiovascular Diseases Vascular Diseases Arteriosclerosis Arterial Occlusive Diseases

ClinicalTrials.gov processed this record on September 29, 2016

To Top